$BMNM

BIMINI CAPITAL MANAGEMENT, INC. (BMNM): Results of Operations and Financial Condition

BIMINI CAPITAL MANAGEMENT, INC. (BMNM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIMINI CAPITAL MANAGEMENT ANNOUNCES Second QUARTER 2026 RESULTS VERO BEACH, Fla., ( August 6, 2026 ) – Bimini Capital Management, Inc. (OTCQX: BMNM), (“Bimini Capital,” “Bimini,” or the “Company”), today announced results of operations for the six and three-month per

Original reporting
Published Aug 6, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BMNM
Bullish
medium confidence
Mentioned
$BMNM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BMNMBullishMed
01

Why it matters

The 8-K details Q2 and six-month results, including advisory services revenue growth from Orchid and TJIM, while MBS interest income fell after liquidation to fund the TJIM acquisition.

02

Market read

Traders can update near-term expectations for BMNM based on the disclosed quarterly earnings drivers and the ongoing transition from MBS spread income toward advisory fee income.

03

What to watch

MBS interest income declined sharply due to portfolio liquidation for the TJIM acquisition, so future results may depend on whether fee growth fully offsets lower spread income.

Relevance 7/10Novelty 6/10Timing: after-hours filing, results call scheduled for Aug 7, 2026 10:00 AM ET

Background

Bimini Capital Management is an OTC-listed asset manager with an externally managed relationship to Orchid Island Capital and a recent acquisition of 80% of TJIM completed April 1, 2026.

Company-level read

Ticker impact

$BMNMBullishMedium confidence
Context

Bimini reports Q2 2026 net income of $0.4M, advisory revenue growth, and notes TJIM acquisition contribution starting April 1, 2026.

Expected impact

Near-term bias modestly positive if investors focus on advisory fee growth and improved net income versus prior-year quarter.

Evidence & confidence

This is a primary 8-K earnings-style disclosure with multiple line-item changes and a clear operational driver tied to the TJIM acquisition and Orchid equity growth.

Market effects

Adds datapoints on externally managed mortgage REIT-like/BDC-style fee income sensitivity to MBS portfolio size and funding costs.

Limited, primarily affects OTC-listed asset manager sentiment rather than broad regional risk.

Low; commentary references macro rates and MBS conditions but the actionable disclosure is company-specific.

Counterpoint

Net income improvement may be partly offset by higher operating expenses and acquisition-related costs, so the quality of earnings could be questioned.

Key entities

  • Bimini Capital Management, Inc.

    OTCQX-listed company reporting Q2 2026 results and describing drivers including Orchid fee income and TJIM acquisition contribution.

  • Orchid Island Capital, Inc.

    Externally managed by Bimini Advisors; Orchid generated a 6.21% Q2 2026 return and increased average equity.

  • Bimini Advisors, LLC

    Registered investment advisor subsidiary that administers Orchid and earns advisory services revenue.

  • Tom Johnson Investment Management, LLC (TJIM)

    Privately held SEC-registered investment adviser acquired 80% of by Bimini Advisors Holdings on April 1, 2026.

Related articles

$LULUMedAI 8/10

Jim Cramer Says Lululemon (LULU) is in “No Man’s Land” After Another Brutal Quarter

Jim Cramer criticized lululemon athletica inc. (LULU) after its Q2 results, citing demand deterioration, competition, and execution issues. Revenue fell 4% YoY to $2.4B, and comparable sales declined 9%. LULU cut its full-year revenue forecast to $10.35B-$10.50B and EPS outlook to $9.48-$9.73. Cramer warned against buying the stock due to structural competitive problems and leadership changes.

$AMRCHighAI 8/10

Ameresco’s (AMRC) Data Center Boom Masks A Cash Flow Problem

Ameresco (AMRC) reported record $1.8B in new project awards for Q2 2026, with $1.2B tied to data center power projects. Total backlog rose 32% YoY to $6.73B. However, net income fell to $9.7M ($0.18 per share) from $12.9M ($0.24) YoY, and the company posted a net loss of $8.6M for H1 2026. Management raised full-year Non-GAAP EPS guidance to $1.15-$1.35, citing tax benefits. Cash increased to $138.3M from $71.8M YoY.

$HUBGMed

Hub Group, Inc. (HUBG): Results of Operations and Financial Condition

Hub Group, Inc. (HUBG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hub Group Announces Select Preliminary First and Second Quarter 2026 Financial Results and Provides Update on Restatement Process OAK BROOK, Ill., September 14, 2026 - Hub Group, Inc. (Nasdaq: HUBG) today announced select preliminary, unaudited financial results for

$DOLEMed

Dole’s (DOLE) Revenue Climbs While Fruit Costs Squeeze Profits

Dole plc (DOLE) reported Q2 2026 revenue up 2.9% to $2.499B, net income more than doubled to $35.1M, but Adjusted EBITDA fell 14.8% due to higher fruit sourcing costs. Diversified Fresh Produce segment saw revenue rise 13.9%, while Fresh Fruit segment's EBITDA dropped 30.9%. The company completed two deals, declared a dividend, and repurchased stock. DOLE cited elevated costs and geopolitical uncertainty for the complex operating environment.

$KRHighAI 8/10

Kroger trims 2026 sales outlook despite profit gains

Kroger reduced its 2026 identical sales growth forecast to 0.2%-0.8% from 1%-2%. Q2 2026 sales rose to $34.62bn, with identical sales up 0.2%. Operating profit increased to $971m, and EPS grew to $1.05. The company cited higher fuel sales and costs but maintained other full-year targets. CEO Greg Foran highlighted progress in customer value and cost management.

$STAAMed

Is STAAR Surgical (STAA) A Bargain Following Its Profit Turnaround And China Led Sales Rebound?

STAAR Surgical (STAA) reported a 111% year-over-year increase in net sales to $93.5M, with China contributing over half. Net income turned positive at $8.1M. Despite this, the stock is down 11.88% over 30 days and 16.62% over a year. The company has no debt and significant cash reserves. Analysts suggest it may be undervalued with a fair value estimate of $29.67.